[Effects of rosuvastatin on arterial stiffness in hyperlipidemia patients].
OBJECTIVE
To evaluate the effects of rosuvastatin on arterial stiffness in hyperlipidemia patient without hypertension.


METHODS
A total of 60 patients without hypertension received rosuvastatin (10 mg, n = 60) daily for 12 weeks while another 60 subjects used no statins. Brachial-ankle pulse wave velocity (ba-PWV), radial artery augmentation index of reflected wave (rAI) and metabolic index were measured before and after treatment.


RESULTS
There were no significant change before and after non-statin treatment. Total cholesterol (TC) and low density lipoprotein cholesterol (LDL-C) levels decreased dramatically after resuvastin treatment [TC: (4.0 ± 1.0) vs (5.8 ± 1.1) mmol/L; LDL-C: (2.1 ± 0.7) vs (3.8 ± 0.7) mmol/L, both P < 0.01]. In rosuvastatin group, ba-PWV and rAI decreased significantly [ba-PWV: (1 340 ± 177) vs (1 477 ± 159) cm/s; rAI: (44 ± 13) % vs (57 ± 15) %, P < 0.01 and P < 0.05).


CONCLUSIONS
Atherosclerosis may be improved by rosuvastatin treatment in hyerlipidemia patient without hypertension.
Department of Cardiology, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038, China.
Ping
P
Wang
Yingping
Y
Liu
Zuoyan
Z
Wang
Zhinan
Z
Wang
Nannan
N
Zhao
Huiming
H
Ye
Email: renlihui1446@sina.com.
Lihui
L
Ren
D055109:Ankle Brachial Index; D000843:Ankle Joint; D050197:Atherosclerosis; D001783:Blood Flow Velocity; D008078:Cholesterol, LDL; D005464:Fluorobenzenes; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D006949:Hyperlipidemias; D006973:Hypertension; D011673:Pulsatile Flow; D011743:Pyrimidines; D000068718:Rosuvastatin Calcium; D013449:Sulfonamides; D059289:Vascular Stiffness
D008078:Cholesterol, LDL; D005464:Fluorobenzenes; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D011743:Pyrimidines; D013449:Sulfonamides; D000068718:Rosuvastatin Calcium